Literature DB >> 34332468

Challenges in replicating secondary analysis of electronic health records data with multiple computable phenotypes: A case study on methicillin-resistant Staphylococcus aureus bacteremia infections.

Inyoung Jun1, Shannan N Rich1, Zhaoyi Chen2, Jiang Bian2, Mattia Prosperi3.   

Abstract

BACKGROUND: Replication of prediction modeling using electronic health records (EHR) is challenging because of the necessity to compute phenotypes including study cohort, outcomes, and covariates. However, some phenotypes may not be easily replicated across EHR data sources due to a variety of reasons such as the lack of gold standard definitions and documentation variations across systems, which may lead to measurement error and potential bias. Methicillin-resistant Staphylococcus aureus (MRSA) infections are responsible for high mortality worldwide. With limited treatment options for the infection, the ability to predict MRSA outcome is of interest. However, replicating these MRSA outcome prediction models using EHR data is problematic due to the lack of well-defined computable phenotypes for many of the predictors as well as study inclusion and outcome criteria.
OBJECTIVE: In this study, we aimed to evaluate a prediction model for 30-day mortality after MRSA bacteremia infection diagnosis with reduced vancomycin susceptibility (MRSA-RVS) considering multiple computable phenotypes using EHR data.
METHODS: We used EHR data from a large academic health center in the United States to replicate the original study conducted in Taiwan. We derived multiple computable phenotypes of risk factors and predictors used in the original study, reported stratified descriptive statistics, and assessed the performance of the prediction model.
RESULTS: In our replication study, it was possible to (re)compute most of the original variables. Nevertheless, for certain variables, their computable phenotypes can only be approximated by proxy with structured EHR data items, especially the composite clinical indices such as the Pitt bacteremia score. Even computable phenotype for the outcome variable was subject to variation on the basis of the admission/discharge windows. The replicated prediction model exhibited only a mild discriminatory ability.
CONCLUSION: Despite the rich information in EHR data, replication of prediction models involving complex predictors is still challenging, often due to the limited availability of validated computable phenotypes. On the other hand, it is often possible to derive proxy computable phenotypes that can be further validated and calibrated.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computable phenotype; Electronic health record; Methicillin-resistant Staphylococcus aureus

Mesh:

Substances:

Year:  2021        PMID: 34332468      PMCID: PMC8451470          DOI: 10.1016/j.ijmedinf.2021.104531

Source DB:  PubMed          Journal:  Int J Med Inform        ISSN: 1386-5056            Impact factor:   4.730


  32 in total

1.  Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.

Authors:  J M Mylotte; A Tayara
Journal:  Clin Infect Dis       Date:  2000-11-07       Impact factor: 9.079

2.  Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples.

Authors:  Enrique F Schisterman; Neil J Perkins; Aiyi Liu; Howard Bondell
Journal:  Epidemiology       Date:  2005-01       Impact factor: 4.822

3.  Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus.

Authors:  Wei-Qi Wei; Cynthia L Leibson; Jeanine E Ransom; Abel N Kho; Pedro J Caraballo; High Seng Chai; Barbara P Yawn; Jennifer A Pacheco; Christopher G Chute
Journal:  J Am Med Inform Assoc       Date:  2012-01-16       Impact factor: 4.497

Review 4.  Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary.

Authors:  J W Chow; V L Yu
Journal:  Int J Antimicrob Agents       Date:  1999-01       Impact factor: 5.283

5.  pROC: an open-source package for R and S+ to analyze and compare ROC curves.

Authors:  Xavier Robin; Natacha Turck; Alexandre Hainard; Natalia Tiberti; Frédérique Lisacek; Jean-Charles Sanchez; Markus Müller
Journal:  BMC Bioinformatics       Date:  2011-03-17       Impact factor: 3.307

6.  Glycopeptide resistance in gram-positive cocci: a review.

Authors:  S Sujatha; Ira Praharaj
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-06-19

7.  Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia.

Authors:  Emi Minejima; Vanessa Delayo; Mimi Lou; Pamela Ny; Paul Nieberg; Rosemary C She; Annie Wong-Beringer
Journal:  BMC Infect Dis       Date:  2019-02-13       Impact factor: 3.090

8.  Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.

Authors:  Athena P Kourtis; Kelly Hatfield; James Baggs; Yi Mu; Isaac See; Erin Epson; Joelle Nadle; Marion A Kainer; Ghinwa Dumyati; Susan Petit; Susan M Ray; David Ham; Catherine Capers; Heather Ewing; Nicole Coffin; L Clifford McDonald; John Jernigan; Denise Cardo
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-03-08       Impact factor: 17.586

9.  Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence.

Authors:  Victoria L Bartlett; Sanket S Dhruva; Nilay D Shah; Patrick Ryan; Joseph S Ross
Journal:  JAMA Netw Open       Date:  2019-10-02

10.  Risk factors of treatment failure and 30-day mortality in patients with bacteremia due to MRSA with reduced vancomycin susceptibility.

Authors:  Chien-Chang Yang; Cheng-Len Sy; Yhu-Chering Huang; Shian-Sen Shie; Jwu-Ching Shu; Pang-Hsin Hsieh; Ching-Hsi Hsiao; Chih-Jung Chen
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.